Low risk of serological cross-reactivity between dengue and COVID-19
Mem. Inst. Oswaldo Cruz
; 115: e200225, 2020.
Article
em En
| LILACS, SES-SP
| ID: biblio-1135239
Biblioteca responsável:
BR1.1
ABSTRACT
In the near future, the overlap of Coronavirus disease 2019 (COVID-19) and dengue epidemics is a concrete threat in tropical regions. Co-epidemics of COVID-19 and dengue could be an overwhelming challenge for health systems in low- and middle-income countries. In this work, we investigated potential serological cross-reactions between COVID-19 and dengue patients. Among 32 COVID-19 positive sera, no positive Dengue virus (DENV) IgG/IgM results were observed. On the other hand, one false-positive result was observed among 44 DENV-positive sera tested for COVID-19 antibodies with each of the two rapid tests used. Further data on accuracy of COVID-19 diagnostic test are urgently warranted.
Palavras-chave
Texto completo:
1
Bases de dados:
LILACS
Assunto principal:
Pneumonia Viral
/
Infecções por Coronavirus
/
Reações Cruzadas
/
Dengue
/
Anticorpos Antivirais
Tipo de estudo:
Etiology_studies
/
Risk_factors_studies
Limite:
Humans
Idioma:
En
Revista:
Mem. Inst. Oswaldo Cruz
Assunto da revista:
MEDICINA TROPICAL
/
PARASITOLOGIA
Ano de publicação:
2020
Tipo de documento:
Article
País de afiliação:
Itália